Anthropic × Adaptyv protein design challenge 3 targets GLP1R, the Ozempic receptor
AllThingsApx · x · 2026-10-13
Challenge 3 of the Anthropic × Adaptyv Protein Design Competition is open. Participants must design a protein that switches on GLP1R — the receptor targeted by semaglutide (Ozempic, Wegovy) and tirzepatide in type 2 diabetes and obesity treatments.
- Format: AI-designed proteins are synthesized and experimentally validated in the lab
- The challenge ties frontier AI capabilities to a real drug-discovery problem in metabolic disease
More from Apps
- TBD Labs launches Muse Wonder agents for delegating real work — EdwardSun0909 · 2026-10-13
- Every's guide to voice-driven agents: patch bugs and write by talking — every · 2026-10-13
- Solo dev turns old laptops into free security guards with local LLMs via Observer — Roy3838 · 2026-10-13
- Radical Pie equation editor turns one with 16 major updates, $60 one-time license — EricLengyel · 2026-10-13
- Fitness app with 7,000-exercise library ships MCP for ChatGPT, Claude and Cursor — JustSuperHuman · 2026-10-13
- Postedly MCP lets AI agents send physical mail and faxes with human review — sparkignitefire · 2026-10-13